Comparison of drugeluting stents to baremetal stents in STelevation myocardial infarction in longterm followup

Kardiologia Polska

Volumn 71, Issue 1, 2013, Pages 25-31

  Kubler, Piotr ^a   Jankowska, Ewa A ^a,b   Ferenc, Mirosaw ^c   Ponikowski, Piotr ^a,b   Banasiak, Waldemar ^a   Reczuch, Krzysztof ^a,b  

^a MILITARY HOSPITAL   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Herz Zentrum Bad   (Germany)

Author keywords

Drug eluting stents; Primary percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PACLITAXEL; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; TROPONIN; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT; METAL;

ADULT; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; DEVICE SAFETY; ELECTROCARDIOGRAPHY; EVALUATION; MIDDLE AGED; MORTALITY; STENT; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84872941686     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet, 2003; 361: 13-20.
2. De Luca G, Suryapranata H, Stone GW et al. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol, 2008; 126: 37-44.
3. Kastrati A, Mehilli J, Pache J et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med, 2007; 356: 1030-1039.
4. Lagerqvist B, James SK, Stenestrand U et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med, 2007; 356: 1009-1019.
5. Piscione F, Piccolo R, Cassese S et al. Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing pecutaneous coronary intervention: a meta-analysis of randomized trials and an adjusted indirect comparison. Eurointervention, 2010; 5: 853-860.
6. Kaltoft A, Kelbaek H, Thuesen L et al. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION trial. J Am Coll Cardiol, 2010; 56: 641-645.
7. Boden H, van der Hoeven BL, Liem SS et al. Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial. Eurointervention, 2011; 7: 1021-1029.
8. Vink MA, Dirksen MT, Suttorp MJ et al. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv, 2011; 4: 24-29.
9. Lemos PA, Saia F, Hofman SH et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol, 2004; 43: 704-708.
10. Mauri L, Silbaugh TS, Garg P et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med, 2008; 359: 1330-1342.
11. Steg PG, Fox KA, Eagle KA et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J, 2009; 30: 321-329.
12. Tolleson TR, Newby LK, Harrington RA et al. Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). Am J Cardiol, 2003; 92: 330-333.
13. Luscher TF, Steffel J, Eberli FR et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation, 2007; 115: 1051-1058.
14. Daemen J, Tanimoto S, Garcia-Garcia HM et al. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol, 2007; 99: 1027-1032.
15. Brodie B, Pokharel Y, Fleishman N et al. Very late stent thrombosis after primary percutaneous coronary intervention with baremetal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience. J Am Coll Cardiol Intv, 2011; 4: 30-38.
16. Stone GW, Lansky AJ, Pocock SJ et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med, 2009; 360: 1946-1959.
17. Valgimigli M, Percoco G, Malagutti P et al. Tirofiban and sirolimuseluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA, 2005; 293: 2109-2117.
18. Spaulding C, Henry P, Teiger E et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med, 2006; 355: 1093-1104.
19. Menichelli M, Parma A, Pucci E et al. Randomized trial of Sirolimus- Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol, 2007; 49: 1924-1930.
20. Van der Hoeven BL, Liem SS, Jukema JW et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. J Am Coll Cardiol, 2008; 51: 618-626.
21. Dibra A, Tiroch K, Schulz S et al. Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol, 2010; 99: 345-357.
22. Wijns W, Kolh P, Danchin N et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2010; 31: 2501-2555.
23. Kushner FG, Hand M, Smith SC et al. 2009 focused updates: ACC/ /AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2009; 54: 2205-2241.
24. Witkowski A, Opolski M, Dudek D et al. Stanowisko grupy ekspertow dotyczce zastosowania stentow oraz balonow uwalniajcych leki antyproliferacyjne u pacjentow z chorob wiecow przyjte przez Asocjacj Interwencji Sercowo-Naczyniowych i Polskie Towarzystwo Kardiologiczne. Kardiol Pol, 2011; 69 (suppl. 1): 1-36.
25. Killip T, Kimball J. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol, 1967; 20: 457-464.